Definitive Healthcare Corp.

NASDAQ:DH

Medical - Healthcare Information Services

Healthcare
$1.34 +1.85%

+$0.01 today

Market cap
$143.60M
Beta
1.33
P/E (TTM)
-0.5
EPS (TTM)
-$1.63
52W Low $0.77High $4.70

Volume 0.43M

Average 0.32M

DH Net Income

Bottom-line profit, the starting point for calculating cash from operations.

Definitive Healthcare Corp.NASDAQ: DH

Net Income · Q1 FY2026 · quarter ended Mar 2026

Net income declines year over year

Q1 FY2026 net income of $138.62M (cash outflow) fell 10.6% year over year, ahead of the -71.5% change in trailing-twelve-month net income. Sequentially, it rose 708.4% from the prior quarter. Over 3 fiscal years it compounded at +107.7% a year.

Context

  • Net income amounted to 82.5% of revenue in FY2025, down 152.0 pp from a year earlier.
  • Net income grew in size in 2 of the last 3 fiscal years.

What to watch

Whether net income reaches the consensus estimate from 3 analysts of $22.28M (+111.2%) for the fiscal year ending Dec 2026, a step up from the -66.3% reported in FY2025.

Sources:Cash Flow Analyst consensus estimates Text generated from reported figures; not investment advice.

Latest quarterMar 2026
-$138.62M+708.4% QoQ
Last fiscal yearDec 2025
-$199.3M-66.3% YoY
LTMMar 2026
-$182.83M-71.5% YoY
Net Income past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-10.6%+149.2%+159.8 pp
1 year-66.3%+111.2%+177.5 pp
3-year CAGR+107.7%——
5-year CAGR——
10-year CAGR——

Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.

Net Income history

USD · from the cash flow

Latest · FY2025
(199.3M) USD
Year-over-year change
+66.3%
Reported Analyst consensus estimate Further estimates hidden. Sign in to unlock

Net Income vs competitors

How DH compares with its peers on the latest reported figures

  • DH's LTM Mar 2026 net income of $182.83M is the 2nd largest of the 10 companies compared; the peer median is $80.17M.
  • Its year-over-year change of -71.5% is the 9th highest of 10, against a peer median of +7.6%.
  • Net income amounts to 76.7% of revenue for DH, versus a peer median of 78.0%.
DH Competitors Peer median
Net Income for DH and competitors
Company Period LTM YoY 3-year CAGR% of revenue
NAKANakamoto Inc.LTM Mar 2026$289.97M +6530.4%+173.9%7397.8%
DHDefinitive Healthcare Corp.LTM Mar 2026$182.83M -71.5%+107.7%76.7%
CABACabaletta Bio, Inc.LTM Mar 2026$175.43M +38.4%+46.9%—
KYTXKyverna Therapeutics, Inc.LTM Mar 2026$156.4M +7.6%+77.4%—
EDITEditas Medicine, Inc.LTM Mar 2026$108.95M -56.6%-10.1%281.6%
SOPHSOPHiA GENETICS S.A.LTM Mar 2026$80.17M +23.8%-3.4%98.8%
SLPSimulations Plus, Inc.LTM Feb 2026$62.79M -964.8%—78.0%
TBRGTruBridge, Inc.LTM Mar 2026$16.51M +191.1%-35.0%4.8%
SPOKSpok Holdings, Inc.LTM Mar 2026$12.67M -20.4%-10.1%9.3%
NRCNational Research CorporationLTM Mar 2026$9.04M -62.7%-28.5%6.5%
Peer median (excluding DH) $80.17M+7.6%-6.7%78.0%

Competitors are the stored peer set for DH. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income(62.32M)(22.26M)(202.39M)(591.45M)(199.3M)
Depreciation & Amortization59.95M56.9M51.75M51.67M56.11M
Deferred Income Tax(587K)(26.67M)(18.71M)(119.58M)(10.88M)
Stock-Based Compensation9.96M36.43M48.74M38.09M29.14M
Change in Working Capital(2.51M)(21.95M)(30.39M)(25.93M)(9.42M)
Accounts Receivables(10.73M)(13.22M)811K5.69M1.38M
Inventory00000
Accounts Payables3.42M358K1.33M(5.46M)(1.09M)
Other Working Capital4.79M(9.09M)(32.53M)(26.17M)(9.71M)
Other Non-Cash Items20.73M13.12M192.19M705.4M188.12M
Operating Cash Flow25.21M35.58M41.19M58.2M53.78M
Capital Expenditures(6.73M)(8.33M)(2.98M)(12.34M)(16.72M)
Acquisitions (Net)(40M)(56.3M)(45.02M)(13.53M)0
Purchases of Investments0(337.96M)(259.21M)(304.3M)(64.07M)
Sales of Investments0153.68M275.43M303.77M234.66M
Other Investing Activities00000
Investing Cash Flow(46.73M)(248.9M)(31.78M)(26.41M)153.88M
Debt Repayment(199.46M)(6.88M)(8.59M)(13.75M)(79.47M)
Common Stock Issued834.95M(1.73M)(30K)00
Common Stock Repurchased(231.77M)00(22.37M)(49.45M)
Dividends Paid(8.13M)(12.87M)(12.28M)(5.14M)(3.15M)
Other Financing Activities(11.22M)(5.22M)(4.68M)(15.5M)(18.72M)
Financing Cash Flow384.37M(26.7M)(25.58M)(56.75M)(150.79M)
Effect of Forex Changes(129K)(544K)218K(636K)1.39M
Net Change in Cash362.72M(240.56M)(15.96M)(25.6M)58.25M
Free Cash Flow18.48M27.25M38.21M45.85M37.06M

Definitive Healthcare Corp.

NASDAQ:DH

Intrinsic Alpha fair value

Locked

Current Price

$1.34

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.